IDH1 and glioblastoma: IDH1-wildtype (IDH1-wt) and unmethylated MGMT had higher CD146 levels compared with IDH-mutant (IDH-mut) and methylated MGMT (Fig. 1D, E), indicating that elevated CD146 expression is associated with aggressive GBM properties.